These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1439322)

  • 21. Time of onset, viral load, relapse, and duration of active cytomegalovirus infection in bone marrow transplant outcomes.
    Habib K; Lamia T; Amel L; Abdelrahmen A; Saloua L; Hana E; Amine S; Bechir Z; Tarek BO; Assia BH
    Exp Clin Transplant; 2008 Mar; 6(1):67-73. PubMed ID: 18405248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytomegalovirus induces interstitial lung disease in allogeneic bone marrow transplant recipient rats independent of acute graft-versus-host response.
    Stals FS; Steinhoff G; Wagenaar SS; van Breda Vriesman JP; Haverich A; Dormans P; Moeller F; Bruggeman CA
    Lab Invest; 1996 Feb; 74(2):343-52. PubMed ID: 8780154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Graft versus host-associated pulmonary disease and other idiopathic pulmonary complications after hematopoietic stem cell transplant.
    Watkins TR; Chien JW; Crawford SW
    Semin Respir Crit Care Med; 2005 Oct; 26(5):482-9. PubMed ID: 16267699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary complications following bone marrow transplantation.
    Chan CK; Hyland RH; Hutcheon MA
    Clin Chest Med; 1990 Jun; 11(2):323-32. PubMed ID: 2189666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary resection for fungal infection in children undergoing bone marrow transplantation.
    Lupinetti FM; Behrendt DM; Giller RH; Trigg ME; de Alarcon P
    J Thorac Cardiovasc Surg; 1992 Sep; 104(3):684-7. PubMed ID: 1513157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus as a cause of very late interstitial pneumonia after bone marrow transplantation.
    de Medeiros CR; Moreira VA; Pasquini R
    Bone Marrow Transplant; 2000 Aug; 26(4):443-4. PubMed ID: 10982292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
    Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
    Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interstitial pneumonia after allogeneic and autologous bone marrow transplantation.
    Funada H; Harada M; Yoshida T; Hattori K
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():519-30. PubMed ID: 6097710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pulmonary complications after bone marrow transplantation].
    Teschler H; Quabeck K; Schäfer UW; Konietzko N; Costabel U
    Pneumologie; 1994 Feb; 48(2):131-9. PubMed ID: 8183864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality.
    Robin M; Guardiola P; Dombret H; Baruchel A; Esperou H; Ribaud P; Devergie A; Gluckman E; Socié G
    Bone Marrow Transplant; 2003 May; 31(10):877-87. PubMed ID: 12748664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pulmonary complications in bone marrow transplantation: a practical approach to diagnosis and treatment.
    Yen KT; Lee AS; Krowka MJ; Burger CD
    Clin Chest Med; 2004 Mar; 25(1):189-201. PubMed ID: 15062610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infection after pediatric heart transplantation: results of a multiinstitutional study. The Pediatric Heart Transplant Study Group.
    Schowengerdt KO; Naftel DC; Seib PM; Pearce FB; Addonizio LJ; Kirklin JK; Morrow WR
    J Heart Lung Transplant; 1997 Dec; 16(12):1207-16. PubMed ID: 9436132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical, diagnostic and physiopathological aspects of cytomegalovirus pneumonia after bone marrow transplantation].
    Cordonnier C
    Rev Pneumol Clin; 1990; 46(6):244-50. PubMed ID: 1965751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of bronchoalveolar lavage cytology and determination of protein contents in pulmonary complications of bone marrow transplant recipients.
    Leskinen R; Taskinen E; Volin L; Tukiainen P; Ruutu T; Häyry P
    Bone Marrow Transplant; 1990 Apr; 5(4):241-5. PubMed ID: 2159819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring of C-reactive protein after allogeneic bone marrow transplantation identifies patients at risk of severe transplant-related complications and mortality.
    Schots R; Kaufman L; Van Riet I; Lacor P; Trullemans F; De Waele M; Van Camp B
    Bone Marrow Transplant; 1998 Jul; 22(1):79-85. PubMed ID: 9678800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of infectious complications of bone marrow transplantation.
    Wingard JR
    Oncology (Williston Park); 1990 Feb; 4(2):69-75; discussion 76, 81-2. PubMed ID: 2143670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the pattern of interstitial pneumonitis following allogeneic bone marrow transplantation before and after the introduction of prophylactic ganciclovir therapy in 1989.
    Atkinson K; Nivison-Smith I; Dodds A; Concannon A; Milliken S; Downs K
    Bone Marrow Transplant; 1998 Apr; 21(7):691-5. PubMed ID: 9578309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interstitial pneumonia in bone marrow transplantation. Preventive and therapeutic aspects. Our experience and review of the literature].
    Zabala P; Campano F; Candela MJ; Regidor C; Cabrera R; Sanjuán I; Barbolla L; Fernández MN
    Sangre (Barc); 1989 Dec; 34(6):489-96. PubMed ID: 2483466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.
    van Burik JA; Carter SL; Freifeld AG; High KP; Godder KT; Papanicolaou GA; Mendizabal AM; Wagner JE; Yanovich S; Kernan NA
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1487-98. PubMed ID: 18022579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.